COX2 |
P00403
|
cytochrome c oxidase subunit II
|
Enzyme
|
|
0.352 |
0.962 |
IFNA1 |
P01562
|
interferon alpha 1
|
|
|
0.371 |
0.923 |
IFNA13 |
P01562
|
interferon alpha 13
|
|
|
0.374 |
0.923 |
IFNA2 |
P01563
|
interferon alpha 2
|
|
|
0.442 |
0.885 |
PART1 |
|
prostate androgen-regulated transcript 1
|
|
|
0.483 |
0.885 |
MIR214 |
|
microRNA 214
|
|
|
0.480 |
0.808 |
MIR18A |
|
microRNA 18a
|
|
|
0.520 |
0.846 |
FPR1 |
P21462
|
formyl peptide receptor 1
|
G-protein coupled receptor
|
|
0.576 |
0.769 |
HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
PSORS1C3 |
|
psoriasis susceptibility 1 candidate 3
|
|
|
0.769 |
0.269 |
ATP6V1G2-DDX39B |
|
ATP6V1G2-DDX39B readthrough (NMD candidate)
|
|
|
0.769 |
0.423 |
ABCG2 |
Q9UNQ0
|
ATP binding cassette subfamily G member 2 (Junior blood group)
|
Transporter
|
2.1E-32 |
0.419 |
0.885 |
CYP2D6 |
P10635
|
cytochrome P450 family 2 subfamily D member 6
|
|
1.1E-25 |
0.437 |
0.885 |
PROM1 |
O43490
|
prominin 1
|
Transporter
|
1.9E-22 |
0.410 |
0.846 |
CYP2C19 |
P33261
|
cytochrome P450 family 2 subfamily C member 19
|
|
6.5E-20 |
0.467 |
0.846 |
HSPG2 |
P98160
|
heparan sulfate proteoglycan 2
|
Enzyme modulator
|
1.0E-19 |
0.438 |
0.885 |
ABCB6 |
Q9NP58
|
ATP binding cassette subfamily B member 6 (Langereis blood group)
|
Transporter
|
8.6E-19 |
0.431 |
0.885 |
CABIN1 |
Q9Y6J0
|
calcineurin binding protein 1
|
Enzyme modulator
|
3.3E-17 |
0.536 |
0.846 |
PCM1 |
Q15154
|
pericentriolar material 1
|
|
3.7E-16 |
0.644 |
0.615 |
NOS2 |
P35228
|
nitric oxide synthase 2
|
|
4.0E-15 |
0.364 |
0.923 |
RIPK3 |
Q9Y572
|
receptor interacting serine/threonine kinase 3
|
Kinase
|
1.2E-14 |
0.497 |
0.885 |
MLKL |
Q8NB16
|
mixed lineage kinase domain like pseudokinase
|
Kinase
|
2.1E-14 |
0.570 |
0.731 |
GZMB |
P10144
|
granzyme B
|
Enzyme
|
3.7E-14 |
0.453 |
0.808 |
NEDD4 |
P46934
|
NEDD4 E3 ubiquitin protein ligase
|
Enzyme
|
8.7E-13 |
0.569 |
0.846 |
CYP3A4 |
P08684
|
cytochrome P450 family 3 subfamily A member 4
|
Enzyme
|
5.8E-11 |
0.462 |
0.885 |